Ahead of a new report, the Association for Decentralised Energy’s Chief Strategic Advisor Joanne Wade, examines the role of the public sector in leading the energy transition to net-zero.
Gábor Egry, Director-General at the Institute of Political History and principal investigator of Horizon 2020 funded project NEPOSTRANS, dissects the ideologies that shaped and outlived the Habsburg Empire.
Professor Neophytos Neophytou sheds some light on nanostructures and explains how the Horizon 2020 NANOthermMA project could eventually enable a strong boost in thermoelectric technology.
Professor Georgiy Stenchikov, Chair of Earth Sciences and Engineering Program at King Abdullah University of Science and Technology (KAUST), explains how MENA accounts for more than half of global dust emissions, and the immense strain on the environment dust can cause.
Chris Girard, Associate Professor at Florida International University, explores COVID-19 and coevolving informatics, including comment on defence logic from meiosis to AI.
Romy Rawlings, Commercial Director at Vestre Ltd, discusses how COVID-19 has acted as a catalyst for transforming urban spaces, and why introducing parklets could be the way forward.
Ignacio Pagonabarraga, Director of CECAM, lifts the lid on the field of computer simulations and the crucial role they have played in the development of science since the second half of the last century.
Carsten Østergård Pedersen, Head of District Energy at Grundfos Holding A/S, speaks to Open Access Government about the enormous benefits of intelligent district heating, and why sustainability should remain at the heart of innovation.
AFTER-BIOCHEM project aims at creating innovative and more sustainable value chains from renewable raw materials to multiple high added-value products at industrial scale.
The 2020 COVID-19 pandemic has proven to be an opportunity for 3D printing – EnvisionTEC identified several areas where their specific strengths in biocompatible materials could help to provide replenishment of stocks as well as new, alternative solutions.
Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.
